Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.

Anti-counterfeit technologies: a pharmaceutical industry perspective.

Bansal D, Malla S, Gudala K, Tiwari P.

Sci Pharm. 2013 Jan-Mar;81(1):1-13. doi: 10.3797/scipharm.1202-03. Epub 2012 Oct 9.

2.

RFID in the pharmaceutical industry: addressing counterfeits with technology.

Taylor D.

J Med Syst. 2014 Nov;38(11):141. doi: 10.1007/s10916-014-0141-y. Epub 2014 Oct 12.

PMID:
25308613
3.

Effects of radio frequency identification-related radiation on in vitro biologics.

Uysal I, Hohberger C, Rasmussen RS, Ulrich DA, Emond JP, Gutierrez A.

PDA J Pharm Sci Technol. 2012 Jul-Aug;66(4):333-45. doi: 10.5731/pdajpst.2012.00875.

PMID:
22767882
4.

Could the Pharmaceutical Industry Benefit from Full-Scale Adoption of Radio-Frequency Identification (RFID) Technology with New Regulations?

Coustasse A, Kimble CA, Stanton RB, Naylor M.

Perspect Health Inf Manag. 2016 Oct 1;13(Fall):1b. eCollection 2016 fall.

5.

Role of the pharmacist in preventing distribution of counterfeit medications.

Chambliss WG, Carroll WA, Kennedy D, Levine D, Moné MA, Ried LD, Shepherd M, Yelvigi M.

J Am Pharm Assoc (2003). 2012 Mar-Apr;52(2):195-9. doi: 10.1331/JAPhA.2012.11085. Review.

PMID:
22370383
6.

[Anti-counterfeit activities of pharmaceutical companies in Japan: for patient safety].

Shofuda K, Aragane K, Igari Y, Matsumoto K, Ito K.

Yakugaku Zasshi. 2014;134(2):203-11. Review. Japanese.

8.

Pharmaceutical counterfeiting and the RFID technology intervention.

Coustasse A, Arvidson C, Rutsohn P.

J Hosp Mark Public Relations. 2010 Jul;20(2):100-15. doi: 10.1080/15390942.2010.493369.

PMID:
20582850
9.

A review of existing and emerging digital technologies to combat the global trade in fake medicines.

Mackey TK, Nayyar G.

Expert Opin Drug Saf. 2017 May;16(5):587-602. doi: 10.1080/14740338.2017.1313227. Epub 2017 Apr 7. Review.

PMID:
28349715
10.

Traceability and Risk Analysis Strategies for Addressing Counterfeit Electronics in Supply Chains for Complex Systems.

DiMase D, Collier ZA, Carlson J, Gray RB Jr, Linkov I.

Risk Anal. 2016 Oct;36(10):1834-1843. doi: 10.1111/risa.12536. Epub 2016 Jan 21.

PMID:
26800103
11.

Anticounterfeit packaging technologies.

Shah RY, Prajapati PN, Agrawal YK.

J Adv Pharm Technol Res. 2010 Oct;1(4):368-73. doi: 10.4103/0110-5558.76434.

12.

[Counterfeit drugs in Israel and worldwide. Part II: distribution profile and anti-counterfeiting strategies and actions].

Furman-Assaf S, Tamir O, Marom E, Arieli M, Shemer J.

Harefuah. 2010 Jul;149(7):470-5, 479. Hebrew.

PMID:
21465764
13.
14.

Counterfeit drugs: defining the problem and finding solutions.

Wertheimer AI, Santella TM.

Expert Opin Drug Saf. 2005 Jul;4(4):619-22.

PMID:
16011440
15.

FDA, companies test RFID tracking to prevent drug counterfeiting.

James JS.

AIDS Treat News. 2005 Dec;(417):5-8.

PMID:
16541509
16.

Counterfeit drug demand: perceptions of policy makers and community pharmacists in Sudan.

Alfadl AA, Hassali MA, Ibrahim MI.

Res Social Adm Pharm. 2013 May-Jun;9(3):302-10. doi: 10.1016/j.sapharm.2012.05.002. Epub 2012 Jul 25.

PMID:
22835708
17.

[Counterfeit drugs in Israel and worldwide. Part I: the extent of occurrence and impending threats].

Tamir O, Friedman N, Furman-Assaf S, Marom E, Arieli M, Shemer J.

Harefuah. 2010 Jul;149(7):466-9, 479. Hebrew.

PMID:
21465763
18.

Roles for pharmacy in combatting counterfeit drugs.

Ziance RJ.

J Am Pharm Assoc (2003). 2008 Jul-Aug;48(4):e71-88; quiz e89-91. doi: 10.1331/JAPhA.2008.07069. Review.

PMID:
18653407
19.

Substandard and counterfeit medicines: a systematic review of the literature.

Almuzaini T, Choonara I, Sammons H.

BMJ Open. 2013 Aug 17;3(8):e002923. doi: 10.1136/bmjopen-2013-002923.

20.

Fighting trafficking of falsified and substandard medicinal products in Russia.

Fayzrakhmanov NF.

Int J Risk Saf Med. 2015;27 Suppl 1:S37-40. doi: 10.3233/JRS-150681.

PMID:
26639702

Supplemental Content

Support Center